Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Holmgren

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Expert Review of Vaccines|August 6, 2003
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNAJan Holmgren, Ali M Harandi, Cecil Czerkinsky
Journal of Virology|December 28, 2002
A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infectionAli M Harandi, Kristina Eriksson, Jan Holmgren
Vaccine|October 28, 2008
Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio choleraeErik Nygren, Jan Holmgren, Stephen R Attridge
Vaccine|May 24, 2003
Mucosal immunisation and adjuvants: a brief overview of recent advances and challengesJan Holmgren, Cecil Czerkinsky, Kristina Eriksson, et al.
Scientific Reports|February 28, 2019
Proteomic analysis of cholera toxin adjuvant-stimulated human monocytes identifies Thrombospondin-1 and Integrin-β1 as strongly upregulated molecules involved in adjuvant activityManuela Terrinoni, Jan Holmgren, Michael Lebens, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 16, 2011
Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulationAnnika Borde, Anette Larsson, Jan Holmgren, et al.
Frontiers in Immunology|March 7, 2019
Requirement for Cyclic AMP/Protein Kinase A-Dependent Canonical NFκB Signaling in the Adjuvant Action of Cholera Toxin and Its Non-toxic Derivative mmCTManuela Terrinoni, Jan Holmgren, Michael Lebens, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 11, 2012
Effect of protein release rates from tablet formulations on the immune response after sublingual immunizationAnnika Borde, Annelie Ekman, Jan Holmgren, et al.
Infection and Immunity|January 27, 2004
Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infectionCharlotte Larsson, Jan Holmgren, Gunnar Lindahl, et al.
Infection and Immunity|March 26, 2003
Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 developmentKristina Eriksson, Margareta Fredriksson, Inger Nordström, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Expert Review of Vaccines|August 6, 2003
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNAJan Holmgren, Ali M Harandi, Cecil Czerkinsky
Journal of Virology|December 28, 2002
A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infectionAli M Harandi, Kristina Eriksson, Jan Holmgren
Vaccine|October 28, 2008
Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio choleraeErik Nygren, Jan Holmgren, Stephen R Attridge
Vaccine|May 24, 2003
Mucosal immunisation and adjuvants: a brief overview of recent advances and challengesJan Holmgren, Cecil Czerkinsky, Kristina Eriksson, et al.
Scientific Reports|February 28, 2019
Proteomic analysis of cholera toxin adjuvant-stimulated human monocytes identifies Thrombospondin-1 and Integrin-β1 as strongly upregulated molecules involved in adjuvant activityManuela Terrinoni, Jan Holmgren, Michael Lebens, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 16, 2011
Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulationAnnika Borde, Anette Larsson, Jan Holmgren, et al.
Frontiers in Immunology|March 7, 2019
Requirement for Cyclic AMP/Protein Kinase A-Dependent Canonical NFκB Signaling in the Adjuvant Action of Cholera Toxin and Its Non-toxic Derivative mmCTManuela Terrinoni, Jan Holmgren, Michael Lebens, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 11, 2012
Effect of protein release rates from tablet formulations on the immune response after sublingual immunizationAnnika Borde, Annelie Ekman, Jan Holmgren, et al.
Infection and Immunity|January 27, 2004
Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infectionCharlotte Larsson, Jan Holmgren, Gunnar Lindahl, et al.
Infection and Immunity|March 26, 2003
Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 developmentKristina Eriksson, Margareta Fredriksson, Inger Nordström, et al.
Pageof 13